Blenkiron and colleagues analyzed microRNA (miRNA) expression in human breast cancer, and reported that many miRNAs were differentially expressed between breast cancer subtypes including luminal A and luminal B. They also reported an association between miRNA expression profiling and clinicopathological factors such as ERα status and tumor grade[3]. This evidence concerns the gene ESR1 and breast carcinoma.